XELLIA PHARMACEUTICALS AS
Organization
- CEO
- MK
Michael Kocher1967
- Chairman of the board
- AM
- Years since formation
- 30 years
- since Mar 12, 1995
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 31
Ownership
- Number of shares and share classes
- 19,230,770
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2024
- 83,145,000
- NOK
- Annual total result 2024
- 74,379,000
- NOK
- Total equity 2024
- 707,205,000
- NOK
Last update: Sep 13, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
MK 1967 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
SH 1973 | Deputy Chair | - |
HK 1968 | Board Member | - |
HO 1981 | Alternate Member | - |
FA 1971 | Board Member | - |
AM | Chairman | - |
EB 1966 | Board Member | - |
MG | Board Member | - |
MS | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Last update: Sep 11, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 19,230,770 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -72,000Employees: 0
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 83,145,000 | 85,872,000 | 88,993,000 | 73,253,000 |
Annual Total Result | 74,379,000 | 42,946,000 | 52,097,000 | 18,676,000 |
Total assets | 781,317,000 | 732,234,000 | 680,840,000 | 626,110,000 |
Total liabilities | 74,112,000 | 57,799,000 | 22,296,000 | 19,740,000 |
Total equity | 707,205,000 | 674,435,000 | 658,544,000 | 606,370,000 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 83,145,000 | 85,872,000 | 88,993,000 | 73,253,000 |
Total operating costs | 75,855,000 | 78,890,000 | 82,043,000 | 68,965,000 |
Operating result | 7,290,000 | 6,982,000 | 6,950,000 | 4,288,000 |
Financial income/costs | 78,946,000 | 43,627,000 | 45,147,000 | 14,388,000 |
Profit before tax | 86,236,000 | 50,609,000 | 52,097,000 | 18,676,000 |
Total tax & extraordinary income/cost | 11,857,000 | 7,663,000 | 0 | 0 |
Annual Total Result | 74,379,000 | 42,946,000 | 52,097,000 | 18,676,000 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 519,351,000 | 488,233,000 | 467,799,000 | 445,835,000 |
Total current assets | 261,966,000 | 244,001,000 | 213,041,000 | 180,275,000 |
Total assets | 781,317,000 | 732,234,000 | 680,840,000 | 626,110,000 |
Short term debt | 71,226,000 | 54,428,000 | 18,698,000 | 15,901,000 |
Long term debt | 2,886,000 | 3,371,000 | 3,598,000 | 3,839,000 |
Total liabilities | 74,112,000 | 57,799,000 | 22,296,000 | 19,740,000 |
Contributed capital | 707,205,000 | 674,435,000 | 658,544,000 | 606,370,000 |
Retained earnings | 0 | 0 | 0 | 0 |
Total equity | 707,205,000 | 674,435,000 | 658,544,000 | 606,370,000 |
Total equity and liabilities | 781,317,000 | 732,234,000 | 680,840,000 | 626,110,000 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises